NIPER Hyd hosts outreach programme on SPI schemes, advances in pharma industry

Hyderabad: The Bulk Drug Manufacturers Association (BDMA) in association with the Central department of pharmaceuticals and the Telangana government organised an outreach programme on the Strengthening Pharmaceutical Industries scheme and the recent advances in good manufacturing practices. It was held at the National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad.

The Central Drug Standards Control Organisation (CDSCO) and the Drug Control Administration (DCA), Telangana, are also partners of the programme.

NIPER Hyderabad, Pharmexcil, and Small-scale Industries Development Board of India (SIDBI) are also joining hands to promote industry-academia collaboration and export of pharmaceuticals by strengthening quality infrastructure in pharmaceutical companies with a focus on MSMEs.

The outreach programme focuses on the Centre's Strengthening of Pharmaceutical Industries scheme which was introduced under the ministry of chemicals and fertilisers with a fund allocation of around Rs. 500 crores. It aimed to support the pharma industry with quality control systems and support infrastructure to promote the manufacturing of Active Pharmaceutical Ingredients (API) in the country.

The programme also has a technical session on recent advances in good manufacturing practices and post-Covid challenges and opportunities. Experts from drug regulating agencies and industries will deliver talks on different aspects of good manufacturing practices to the benefit of the pharma industry in general and MSMEs in particular.

T. Harish Rao, Telangana finance and health minister, inaugurated the event on 20 August at NIPER, Hyderabad.

The event is sponsored by Aurobindo Pharma Limited, NATCO Pharma Ltd., Virchow Laboratories Ltd., Porus Laboratories Pvt. Ltd., Suven Pharma Ltd., and Sri Krishna Pharmaceuticals Ltd.